Kahira Pharmaceuticals & Chemical Industries Company (EGX:CPCI)
Egypt flag Egypt · Delayed Price · Currency is EGP
135.92
0.00 (0.00%)
At close: Mar 27, 2025

EGX:CPCI Income Statement

Millions EGP. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Revenue
1,7061,3611,0051,1121,0621,010
Upgrade
Revenue Growth (YoY)
56.72%35.38%-9.61%4.71%5.11%4.93%
Upgrade
Cost of Revenue
998.53843.19767.94785.17793.91750.02
Upgrade
Gross Profit
707.33517.66237.3326.95268.13260.41
Upgrade
Selling, General & Admin
135.2116.67103.71101.7587.6298.97
Upgrade
Other Operating Expenses
122.78115.3256.8533.1124.1822.67
Upgrade
Operating Expenses
257.98231.99160.56134.86111.8121.64
Upgrade
Operating Income
449.35285.6776.74192.08156.33138.77
Upgrade
Interest Expense
-19.19-18.94-3.47---
Upgrade
Interest & Investment Income
20.8814.684.366.873.893.15
Upgrade
Currency Exchange Gain (Loss)
20.8727.8145.83---2.1
Upgrade
Other Non Operating Income (Expenses)
6.826.134.0115.142.842.96
Upgrade
EBT Excluding Unusual Items
478.72315.35127.48214.1163.06142.77
Upgrade
Gain (Loss) on Sale of Assets
-0.01-00.08---0.01
Upgrade
Other Unusual Items
------1.37
Upgrade
Pretax Income
478.71315.35127.56214.1163.06141.39
Upgrade
Income Tax Expense
107.3369.2430.4748.3538.7532.25
Upgrade
Earnings From Continuing Operations
371.38246.1197.09165.74124.3109.14
Upgrade
Net Income
371.38246.1197.09165.74124.3109.14
Upgrade
Net Income to Common
371.38246.1197.09165.74124.3109.14
Upgrade
Net Income Growth
216.15%153.48%-41.42%33.34%13.89%28.14%
Upgrade
Shares Outstanding (Basic)
151515151515
Upgrade
Shares Outstanding (Diluted)
151515151515
Upgrade
EPS (Basic)
24.8716.486.5011.108.327.31
Upgrade
EPS (Diluted)
24.8716.486.5011.108.327.31
Upgrade
EPS Growth
216.15%153.48%-41.42%33.34%13.89%28.14%
Upgrade
Free Cash Flow
149.6719.359.4534.52138.57-30.3
Upgrade
Free Cash Flow Per Share
10.021.300.632.319.28-2.03
Upgrade
Dividend Per Share
12.83012.8305.0005.0004.0002.680
Upgrade
Dividend Growth
156.60%156.60%-25.00%49.25%-
Upgrade
Gross Margin
41.47%38.04%23.61%29.40%25.25%25.77%
Upgrade
Operating Margin
26.34%20.99%7.63%17.27%14.72%13.73%
Upgrade
Profit Margin
21.77%18.09%9.66%14.90%11.70%10.80%
Upgrade
Free Cash Flow Margin
8.77%1.42%0.94%3.10%13.05%-3.00%
Upgrade
EBITDA
465.06301.1488.3207.25156.77139.42
Upgrade
EBITDA Margin
27.26%22.13%8.78%18.64%14.76%13.80%
Upgrade
D&A For EBITDA
15.7115.4711.5615.170.440.65
Upgrade
EBIT
449.35285.6776.74192.08156.33138.77
Upgrade
EBIT Margin
26.34%20.99%7.63%17.27%14.72%13.73%
Upgrade
Effective Tax Rate
22.42%21.96%23.88%22.58%23.77%22.81%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.